Fertility preservation medicine: A new field in the care of young cancer survivors

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 267-273

  Oktay, Kutluk ^a,b   Oktem, Ozgur ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b CENTER FOR HUMAN REPRODUCTION   (United States)

Author keywords

Adolescent; Chemotherapy; Fertility preservation; Menstrual function; Ovarian cryopreservation; Ovary; Pediatric; Pregnancy after cancer; Radiotherapy

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; PROCARBAZINE; SPHINGOSINE 1 PHOSPHATE; ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CRYOPRESERVATION; FERTILITY; GONAD FUNCTION; GROUPS BY AGE; HUMAN; NONHUMAN; OOCYTE; OVARY; OVARY INSUFFICIENCY; PREGNANCY; PRESERVATION; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TISSUE PRESERVATION; ADOLESCENT; ADULT; FEMALE; INFERTILITY; MALE; NEOPLASM; PRESCHOOL CHILD; RADIOTHERAPY; REVIEW; SURVIVOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFERTILITY; MALE; NEOPLASMS; PREGNANCY; RADIOTHERAPY; SURVIVORS;

EID: 67449144203     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22003     Document Type: Conference Paper

References (54)

1. Jemal A, Siegel R,Ward E, et al. Cancer statistics. CA Cancer J Clin 2008;58:71-96.
2. Armstrong GA, Sklar CA, Hudson MM, et al. Long-term health status among survivors of childhood cancer: Does sex matter? J Clin Oncol 2007;25:4477-4489.
3. Critchley HO, Wallace WE. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005;34:64-68.
4. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-266.
5. Saenger P, Wikland KA, Conway GS. et al. Fifth International Symposium on Turner Syndrome. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-3069.
6. Spitz S. The histological effects of nitrogen mustard on human tumours and tissues. Cancer 1948;1:383-398.
7. Stillman RJ, Schinfeld JS, Schiff I, et al. Ovarian failure in long term survivors of childhood malignancy. Am J Obstet Gynecol 1981;139:62-66. (Pubitemid 11213579)
8. Sklar CA. Reproductive physiology and treatment related loss of sex hormone production. Med Pediatr Oncol 1999;33:2-8.
9. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 1999;33:24-28. (Pubitemid 29318660)
10. Bakker B, Oostdijk W, Bresters D, et al. Disturbances of growth and endocrine function after busulfan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004;33:1049-1056. (Pubitemid 38744793)
11. Afify Z, Shaw PJ, Clavano-Harding A, et al. Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2004;25:1087-1092. (Pubitemid 30303599)
12. Wallace W, Shalet SM, Crowne EC, et al. Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis. Clin Oncol 1989;1:75-79. (Pubitemid 19268427)
13. Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab 2006;91:1723-1728.
14. Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: Preterm birth and low birth weight among their children. J Natl Cancer Inst 2006;98:1453-1461. (Pubitemid 44605590)
15. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: Pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update 2005;11:69-89. (Pubitemid 40201977)
16. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007;110:2222-2229. (Pubitemid 350100744)
17. Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res 2007;67:10159-10162. (Pubitemid 350070787)
18. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005;34:25-27.
19. Wallace WHB, Thompson AB, Kelsey TW. Radiosensitivity of the human oocyte. Hum Reprod 2003;18:117-121.
20. Horning SJ, Hoppe RT, Kaplan HS, et al. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304:1377-1382.
21. Lushbaugh CC, Casarett GW. The effects of gonadal irradiation in clinical radiation therapy: A review. Cancer 1976;37:1111-1120.
22. Thibaud E, Ramirez M, Brauner R, et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. J Pediatr 1992;121:880-884.
23. Sarafoglou K, Boulad F, Gillio A, et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130:210-216. (Pubitemid 27495155)
24. Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr 1995;411:57-61.
25. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996;87:3045-3052. (Pubitemid 26102258)
26. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br J Obstet Gynaecol 2002;109:107-114. (Pubitemid 37338030)
27. Critchley HO, Wallace WH, Shalet SM, et al. Abdominal irradiation in childhood: The potential for pregnancy. Br J Obstet Gynaecol 1992;99:392-394.
28. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002;187:1070-1080. (Pubitemid 35178413)
29. Chiarelli AM, Marrett LD, Darlington GA. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology 2000;11:161-166. (Pubitemid 30112016)
30. Boice JD, Tawn EJ, Winther JF, et al. Genetic effects of radiotherapy for childhood cancer. Health Phys 2003;85:65-80. (Pubitemid 36706042)
31. Chow EJ, Friedman DL, Yasui Y, et al. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008;50:854-858. (Pubitemid 351356099)
32. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:1113-1121.
33. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: A meta-analysis. Fertil Steril 2006;86:70-80.
34. Oktay K, Newton H, Aubard Y, et al. Cryopreservation of immature human oocytes and ovarian tissue: An emerging technology? Fertil Steril 1998;69:1-7.
35. Oktay K. Ovarian tissue cryopreservation and transplantation: Preliminary findings and implications for cancer patients. Hum Reprod Update 2001;7:526-534. (Pubitemid 33069610)
36. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 2000;342:1919. (letter). (Pubitemid 30419063)
37. Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840. (Pubitemid 38368830)
38. Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: Is there a germline stem cell connection? Hum Reprod 2006;21:1345-1348.
39. Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410. (Pubitemid 39370715)
40. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318-321. (Pubitemid 41058339)
41. Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: Report of an ongoing experience. Fertil Steril 2008; Nov 13 [Epub ahead of print].
42. Hamre MR, Robison LL, Nesbit ME, et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group. J Clin Oncol 1987;5:1759-1765.
43. Wallace WHB, Shalet SM, Hendry JH, et al. Ovarian failure following abdominal irradiation in childhood: The radiosensitivity of the human oocyte. Br J Radiol 1989;62:995-998.
44. Papadakis V, Vlachopapadopoulou E, Van Syckle K, et al. Gonadal function in young patients successfully treated for Hodgkin disease. Med Pediatr Oncol 1999;32:366-372. (Pubitemid 29196286)
45. Cowles RA, Gewanter RM, Kandel JJ. Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields. Pediatr Blood Cancer 2007;49:339-341.
46. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7:535-543. (Pubitemid 33069611)
47. Guerrere Urbano MT, Nutting CM. Clinical use of intensitymodulated radiotherapy: Part II. Br J Radiol 2004;77:177-182. (Pubitemid 38404782)
48. Ataya K, Rao LV, Lawrence E, et al. Luteinizing hormone releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995;52:365-372.
49. Ataya K, Pydyn E, Ramahi-Ataya A, et al. Is radiation induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists? Preliminary observations. J Clin Endocrinol Metab 1995;8:790-795.
50. Blumenfeld Z, Avivi I, Linn S, et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996;11:1620-1626. (Pubitemid 26318897)
51. Oktay K, Sonmezer M, Oktem O, et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 2007;12:1055-1056. (Pubitemid 350007017)
52. Linch DC, Gosden RG, Tulandi T, et al. Hodgkin's lymphoma: Choice of therapy and late complications. Hematology (Am Soc Hematol Educ Program) 2000; 205-221.
53. Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 1987;19:159-162. (Pubitemid 17059373)
54. Ismail-Khan R, Minton S, Cox C. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy. J Clin Oncol 2008;26:12 (abstr 524).